HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert L Rietschel Selected Research

Robert L Rietschel Research Topics

Disease

24Contact Dermatitis (Eczema, Contact)
09/2016 - 01/2002
11Allergic Contact Dermatitis
09/2016 - 02/2002
9Hypersensitivity (Allergy)
01/2009 - 02/2002
8Dermatitis
01/2009 - 02/2002
2Atopic Dermatitis (Atopic Eczema)
03/2009 - 02/2002
1Inflammation (Inflammations)
07/2008
1Skin Diseases (Skin Disease)
02/2008
1Acne Vulgaris
09/2006
1Cystic Fibrosis (Mucoviscidosis)
09/2006
1Epistaxis (Nosebleed)
09/2006
1Infections
09/2006
1Respiratory Tract Infections (Respiratory Tract Infection)
09/2006
1Latex Hypersensitivity (Latex Allergy)
07/2002

Drug/Important Bio-Agent (IBA)

16AllergensIBA
09/2016 - 12/2002
9Irritants (Vesicants)IBA
09/2016 - 02/2002
5NickelIBA
09/2008 - 02/2002
2Petrolatum (Vaseline)FDA Link
11/2010 - 09/2007
2Propylene Glycol (1,2 Propanediol)FDA LinkGeneric
01/2009 - 09/2008
2Potassium DichromateFDA Link
12/2007 - 02/2002
2Formaldehyde (Formol)FDA Link
12/2007 - 03/2006
2imidazolidinyl ureaIBA
09/2007 - 03/2006
13-iodo-2-propynylbutylcarbamateIBA
11/2010
1LanolinIBA
03/2009
1CosmeticsIBA
01/2009
1Peruvian balsam (balsam of Peru)IBA
09/2008
1CarbamatesIBA
07/2008
1Neoprene (Polychloroprene)IBA
07/2008
1ThioureaIBA
07/2008
1Budesonide (Pulmicort)FDA LinkGeneric
05/2008
1ParabensIBA
05/2008
1Benzocaine (Americaine)FDA Link
03/2008
1Anesthetics (Anesthetic Agents)IBA
03/2008
1Local AnestheticsIBA
03/2008
1MineralsIBA
02/2008
1Materia Medica (Homeopathic Remedies)IBA
02/2008
1carbamixIBA
12/2007
1HydantoinsIBA
09/2007
1diazolidinylurea (diazolidinyl urea)IBA
09/2007
11,3-dimethylol-5,5-dimethylhydantoinIBA
09/2007
1Anti-Bacterial Agents (Antibiotics)IBA
09/2006
1Isotretinoin (Accutane)FDA LinkGeneric
09/2006
1cocamidopropyl betaineIBA
03/2004
1LatexIBA
07/2002
1EnzymesIBA
02/2002
1Detergents (Detergent)IBA
02/2002
1dimethylol dihydroxyethyleneureaIBA
01/2002
1ethylene ureaIBA
01/2002
1ethylene urea melamine formaldehyde resinIBA
01/2002

Therapy/Procedure

1Therapeutics
09/2006